SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David B. Higgs who wrote (159)6/10/1997 12:28:00 AM
From: M. LaMancha   of 371
 
Thanks, Dave. I've followed IMMU for a couple years. I agree the potential of this company seems high. I'm a little worried about its ability to hang on after looking at the 10Q. Losses will outstrip cash reserve in about a year unless revenues increase or new financing is obtained. Obviusly, this is no secret. That's what intrigued me about the specificity of your informatin. Diminishing funds can be a great motivator. Guess we'll see what happens, if anything, in a couple weeks -- if the rumor is true. Again, thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News